Vectorite Biomedical Inc. (TPEX:4170)

Vectorite Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	613	613	635	935	621	621
Market Cap Growth	12.00%	-3.45%	-32.08%	50.46%	-	26.25%
Enterprise Value	443	437	442	728	396	375
Last Close Price	14.00	14.00	14.50	21.35	14.01	14.01
PE Ratio	6.39	6.37	-	-	-	74.32
PS Ratio	9.98	9.98	10.99	16.73	14.47	21.59
PB Ratio	1.26	1.26	1.63	2.17	1.41	1.33
P/TBV Ratio	1.27	1.26	1.66	2.29	1.49	1.40
P/FCF Ratio	-	-	-	-	44.96	-
P/OCF Ratio	-	-	-	719.97	42.25	-
EV/Sales Ratio	7.21	7.12	7.65	13.04	9.23	13.03
EV/FCF Ratio	-45.26	-	-	-	28.67	-
Net Debt / Equity Ratio	-0.35	-0.35	-0.47	-0.47	-0.48	-0.51
Net Debt / EBITDA Ratio	12.38	12.38	10.74	29.21	9.85	9.23
Net Debt / FCF Ratio	17.42	17.42	12.88	58.92	-15.46	3.54
Asset Turnover	0.13	0.13	0.13	0.12	0.09	0.07
Inventory Turnover	2.67	2.67	3.29	5.31	6.99	4.97
Quick Ratio	10.73	10.73	12.91	16.45	14.10	14.53
Current Ratio	11.85	11.85	14.06	17.53	14.93	15.07
Return on Equity (ROE)	21.98%	21.98%	-9.77%	-1.52%	-5.83%	2.05%
Return on Assets (ROA)	-2.97%	-2.97%	-3.75%	-2.20%	-3.98%	-6.15%
Return on Capital Employed (ROCE)	-4.40%	-4.40%	-6.50%	-3.70%	-6.80%	-8.90%
Earnings Yield	15.69%	15.69%	-6.31%	-0.71%	-4.25%	1.35%
FCF Yield	-1.60%	-1.60%	-2.26%	-0.37%	2.22%	-10.88%
Buyback Yield / Dilution	-0.87%	-0.47%	0.14%	-	-1.84%	-47.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.